Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quince Therapeutics (QNCX)
NASDAQ:QNCX
Quince Therapeutics (QNCX) Ownership - Who Owns Quince Therapeutics?
498 Followers
Quince Therapeutics (QNCX) Ownership Overview
53.16% Insiders
3.48% Mutual Funds
13.40% Other Institutional Investors
29.95% Public Companies and
Individual Investors
The ownership structure of Quince Therapeutics (QNCX) stock is a mix of institutional, retail and individual investors. Approximately 16.89% of the company’s stock is owned by Institutional Investors, 53.16% is owned by Insiders and 29.95% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 17, 2024 | Dirk Thye Ceo And Chief Medical Officer,director | Bought | $190791 |
| Dec 14, 2023 | David Lamond Director | Bought | $69233 |
| Dec 07, 2023 | David Lamond Director | Bought | $58134 |
| Dec 01, 2023 | David Lamond Director | Bought | $40546 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,107,943 | Institution | 2.58% | 1,174,420 | |
| 950,666 | Institution | 2.22% | 1,007,706 | |
| 209,074 | Institution | 0.49% | 221,618 | |
| 163,050 | Institution | 0.38% | 172,833 | |
| 138,495 | Institution | 0.32% | 146,805 | |
| 63,747 | Institution | 0.15% | 67,572 | |
| 14,974 | Institution | 0.03% | 15,872 | |
| 11,013 | Institution | 0.03% | 11,674 | |
| 6,194 | Institution | 0.01% | 6,566 | |
| 478 | Institution | <0.01% | 507 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 950,666 | Institution | 2.22% | 1,007,706 | |
| 209,074 | Institution | 0.49% | 221,618 | |
| 163,050 | Institution | 0.38% | 172,833 | |
| 138,495 | Institution | 0.32% | 146,805 | |
| 14,974 | Institution | 0.03% | 15,872 | |
| 11,013 | Institution | 0.03% | 11,674 | |
| 6,194 | Institution | 0.01% | 6,566 | |
| 478 | Institution | <0.01% | 507 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 817,617 | Institution | 1.91% | 1,062,902 | |
| 290,326 | Institution | 0.68% | 377,424 | |
| 63,747 | Institution | 0.15% | 67,572 |
FAQ
Who Owns Quince Therapeutics (QNCX)?
According to the latest TipRanks data, approximately 13.40% of the company's stock is held by institutional investors, 53.16% is held by insiders, and 29.95% is held by retail investors.
What percentage of Quince Therapeutics (QNCX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.40% of Quince Therapeutics (QNCX) stock is held by institutional investors.
What percentage of Quince Therapeutics (QNCX) stock is held by retail investors?
According to the latest TipRanks data, approximately 29.95% of Quince Therapeutics (QNCX) stock is held by retail investors.
Who owns the most shares of Quince Therapeutics (QNCX)?
Vanguard owns the most shares of Quince Therapeutics (QNCX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.